124
Views
4
CrossRef citations to date
0
Altmetric
Review

COVID-19 Pandemic: A Compressive Review on Gender, Herd Immunity, and Physiological Mechanisms

ORCID Icon & ORCID Icon
Pages 2963-2974 | Published online: 14 Dec 2020

References

  • Porta M, editor. A Dictionary of Epidemiology. Oxford university press; 2014.
  • Qui W, Rutherford S, Mao A, Chu C. The pandemic and its impacts. Health Cult Soc. 2017;9–10.
  • The ‘greatest pandemic in history’ was 100 years ago – but many of us still get the basic facts wrong. Available from: https://theconversation.com/the-greatest-pandemic-in-history-was-100-years-ago-but-many-of-us-still-get-the-basic-facts-wrong-8984/. Accessed 812, 2020.
  • Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China. N Engl J Med. 2019.
  • World Health Organization. Coronavirus disease 2019 (COVID-19) situation report. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situationreports/. Accessed 1027, 2020.
  • Randolph HE, Barreiro LB. Herd immunity: understanding COVID-19. Immunity. 2020;52(5):737–741. doi:10.1016/j.immuni.2020.04.01232433946
  • World Health Organization WHO. Summary of probable SARS cases with onset of illness. Available from: http://www.who.int/csr/sars/country/table2004_04_21/en/index.html. Accessed 124, 2020.
  • He X, Lau EHY, Wu P, et al. Temporal dynamics in viral shedding and transmissibility of COVI-19. Nat Med. 2020.
  • Anfinrud P, Stadnytskyi V, Bax CE, Bax A. Visualizing speech-generated oral fluid droplets with laser light scattering. N Engl J Med. 2020;382(21):2061–2063. doi:10.1056/NEJMc200780032294341
  • Zhang H, Kang Z, Gong H, et al. The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. BioRxiv. 2020.
  • Wei WE, Li Z, Chiew CJ, Yong SE, Toh MP, Lee VJ. Presymptomatic transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(14):411. doi:10.15585/mmwr.mm6914e132271722
  • Van Damme W, Dahake R, Delamou A, Ingelbeen B, Wouters E. The COVID-19 pandemic: diverse contexts; different epidemics—how and why? BMJ Glob Health. 2020;5(7):e003098. doi:10.1136/bmjgh-2020-003098
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-531986264
  • Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. 2020;382(13):1199–1207. doi:10.1056/NEJMoa200131631995857
  • Zhang T, Wu Q, Zhang Z. Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak. Curr Biol. 2020;30:1346–1351.32197085
  • Karthick R, Meenalochini P, Dawood MS, Akram M, Selvaprasanth P. A Geographical Review: Novel Coronavirus (COVID-19) Pandemic.
  • Natural News. Coronavirus: a bioweapon or Chinese experiment gone wrong. Available from: http://www.naturalnews.com/2020-coronavirus-bioweapon-chinese-vaccineexperiment-gone-wrong-pshuttle-sn-genesequence.html. Accessed 124, 2020.
  • Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;1–4.
  • Jia HP, Look DC, Shi L, et al. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol. 2005;79(23):14614–14621. doi:10.1128/JVI.79.23.14614-14621.200516282461
  • Sherwood L. Human Physiology: From Cells to Systems. 7th ed. Cengage learning; 2015.
  • Yang JK, Feng Y, Yuan MY, et al. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabetic Med. 2006;23(6):623–628. doi:10.1111/j.1464-5491.2006.01861.x16759303
  • Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020.
  • Monteil V, Kwon H, Prado P, Hagelkrüys A, Wimmer RA. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell. 2020;181(4):905–913.e7. doi:10.1016/j.cell.2020.04.00432333836
  • Turner AJ, Hiscox JA, Hooper NM. ACE2: from vasopeptidase to SARS virus receptor. Trends Pharmacol Sci. 2004;25(6):291–294. doi:10.1016/j.tips.2004.04.00115165741
  • Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450–454. doi:10.1038/nature0214514647384
  • Zheng YY, Ma YT, Zhang JY. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259–260. doi:10.1038/s41569-020-0360-532139904
  • American physiology Societies. Avalaible from: https://www.physiology.org/publications/news/the-physiologistmagazine/2020/september/the-physiology-of-covid-19?SSO=Y[OnlineResource]. Accessed 124, 2020.
  • Eriksson K, Jonsson M, Sjöstrand J. Markov chains on graded posets. Order. 2018;35(1):93. doi:10.1007/s11083-016-9420-1
  • Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the diamond princess cruise ship, Yokohama, Japan, 2020. Euro Surveill. 2020;25(10).
  • Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–481. doi:10.1016/S2213-2600(20)30079-532105632
  • Ludvigsson JF. Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109(6):1088–1095. doi:10.1111/apa.1527032202343
  • World Health Organization. Coronavirus Disease 2019 (COVID-19) Situation Report - 78. Geneva: WHO; 2020.
  • Yang JK, Lin SS, Ji XJ, Guo L-M. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010;47(3):193. doi:10.1007/s00592-009-0109-419333547
  • Li T, Wei C, Li W, Hongwei F, Shi J. Beijing union medical college hospital on” pneumonia of novel coronavirus infection” diagnosis and treatment proposal (V2. 0). Med J Peking Union Med Coll Hosp. 2020.
  • Hu H, Yao N, Qiu Y. Comparing rapid scoring systems in mortality prediction of critical ill patients with novel coronavirus disease. Acad Emerg Med. 2020;27(6):461–468. doi:10.1111/acem.1399232311790
  • Yasin SM, Muzaini K, Samsudin EZ, Selamat MI, Ismail Z. Are our healthcare workers well protected during COVID-19? Learning from current experiences and challenges. J Clin Health Sci. 2020;5(2):4–18. doi:10.24191/jchs.v5i2.8967
  • Millán-Oñate J, Rodriguez-Morales AJ, Camacho-Moreno G, Mendoza-Ramírez H, Rodríguez-Sabogal IA, Álvarez-Moreno C. A new emerging zoonotic virus of concern: the 2019 novel coronavirus (SARS CoV-2). Infection. 2020;24(3):187–192. doi:10.22354/in.v24i3.848
  • Roser M, Ritchie H, Ortiz-Ospina E, Hasell J. Coronavirus Disease (Covid-19)–Statistics and Research. Our World in Data; 2020.
  • Dong Y, Mo XI, Hu Y, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics. 2020;16:16.
  • Roberts S. Embracing the uncertainties. The New-York Times; 2020 Available from: https://www.nytimes.com/2020/04/07/science/coronavirus-uncertainty-scientific-trust.html. Accessed 8, 2020.
  • ClinicalTrials.gov. ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world. Available from: https://www.clinicaltrials.gov/. Accessed 10, 2020.
  • Liu W, Tao ZW, Lei W, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J. 2020.
  • Murad MH, Asi N, Alsawas M, Alahdab F. New evidence pyramid. Evid Based Med. 2016;21(4):125–127. doi:10.1136/ebmed-2016-11040127339128
  • Williams AE. Basic Concepts in Immunology. In: Immunology: Mucosal and Body Surface Defences. Chichester, UK: John Wiley & Sons, Ltd; 2011:1–19.
  • Tosi MF. Innate immune responses to infection. J Allergy Clin Immunol. 2005;116(2):241–249. doi:10.1016/j.jaci.2005.05.03616083775
  • Kowalik MM, Trzonkowski P, Łasińska-Kowara M, Mital A, Smiatacz T. COVID-19—toward a comprehensive understanding of the disease. Cardiol J. 2020;27(2):99–114. doi:10.5603/CJ.a2020.006532378729
  • Yong E. Immunology is where intuition goes to die. The Atlantic, which is too bad because we really need to understand how the immune system reacts to the coronavirus. Available from: https://www.theatlantic.com/health/archive/2020/08/covid-19-immunity-is-the-pandemics-central-mystery/614956/. Accessed 11, 2020.
  • Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):e21. doi:10.1016/S2213-2600(20)30116-832171062
  • Shi Y, Wang Y, Shao C, et al. Giuseppe Ippolito & Gerry Melino COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020;27(1451–1454):1451–1454. doi:10.1038/s41418-020-0530-332205856
  • Racine R, Winslow GM. IgM in microbial infections: taken for granted? Immunol Lett. 2009;125(2):79–85. doi:10.1016/j.imlet.2009.06.00319539648
  • Kakodkar P, Kaka N, Baig M. A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19). Cureus. 2020. doi:10.7759/cureus.7560
  • Phelan AL. COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges. Lancet. 2020;395(10237):1595–1598. doi:10.1016/S0140-6736(20)31034-532380041
  • Brown RC, Kelly D, Wilkinson D, Savulescu J. The scientific and ethical feasibility of immunity passports. Lancet Infect Dis. 2020. doi:10.1016/S1473-3099(20)30766-0
  • Gao Q, Bao L, Mao H, et al. Development of an inactivated vaccine candidate for SARS-CoV-2. Science. 2020;369(6499):77–81. doi:10.1126/science.abc193232376603
  • Callow KA, Parry HF, Sergeant M, Tyrrell DA. The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect. 1990;105(2):435–446. doi:10.1017/S09502688000480192170159
  • Wu LP, Wang NC, Chang YH, et al. Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis. 2007;13(10):1562. doi:10.3201/eid1310.07057618258008
  • Peiris JS, Yuen KY, Osterhaus AD, Stohr K. The severe acute respiratory syndrome. N Engl J Med. 2003;349(25):2431–2441. doi:10.1056/NEJMra03249814681510
  • Seow J, Graham C, Merrick B, et al. Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection. medRxiv. 2020.
  • Pollock AM, Roderick P, Cheng K, Pankhania B. Covid-19: why is the UK government ignoring WHO’s advice? Available from: https://www.bmj.com/content/368/bmj.m1284. Accessed 11, 2020.
  • Metcalf CJ, Ferrari M, Graham AL, Grenfell BT. Understanding herd immunity. Trends Immunol. 2015;36(12):753–755. doi:10.1016/j.it.2015.10.00426683689
  • D’Souza G, Dowdy D. What’s Herd Immunity and How Can We Achieve It with COVID-19. Johns Hopkins School of Public Health Expert Insights; 2020.
  • Anderson RM, May RM. Vaccination and herd immunity to infectious diseases. Nature. 1985;8(6044):323–329.
  • Jones DB. Government of Canada immunization and vaccine-preventable diseases—staying protected. Available from: https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/cphorsphc-respcacsp/2013/assets/pdf/2013-eng.pdf. Accessed 11, 2020.
  • Centers for Disease Control and prevention. Prevention of acquired immune deficiency syndrome (AIDS): report of inter-agency recommendations. MMWR Morb Mortal Wkly Rep. 1983;32:1–125.6405151
  • Fontanet A, Cauchemez S. COVID-19 herd immunity: where are we? Nat Rev Immunol. 2020;20(10):583–584. doi:10.1038/s41577-020-00451-532908300
  • World Health Organization Media Center Immunization Coverage. Available from: http://www.who.int/mediacentre/factsheets/fs378/en/. Accessed 1020, 2020.
  • Lim W, Zhang P. Herd immunity and a vaccination game: an experimental study. PLoS One. 2020;5.
  • Meyer M. The ethics of universal health care in the United States. Reflect Healthcare Manage. 2017;1(1):10.
  • Mallory ML, Lindesmith LC, Baric RS. Vaccination-induced herd immunity: successes and challenges. J Allergy Clin Immunol. 2018;142(1):64–66. doi:10.1016/j.jaci.2018.05.00729803799
  • Betsch C, Böhm R, Korn L, Holtmann C. On the benefits of explaining herd immunity in vaccine advocacy. Nat Hum Behav. 2017;1(3):1–6. doi:10.1038/s41562-017-0056
  • Centers of disease control and prevention (CDC). U.S. public health service syphilis study at Tuskegee. Available from: https://www.cdc.gov/tuskegee/timeline.htm. Accessed 11, 2020.
  • Verelst F, Willem L, Kessels R, Beutels P. Individual decisions to vaccinate one’s child or oneself: a discrete choice experiment rejecting free-riding motives. Soc Sci Med. 2018;207:106–116. doi:10.1016/j.socscimed.2018.04.03829738898
  • Mobaraki K, Ahmadzadeh J. Current epidemiological status of Middle East respiratory syndrome coronavirus in the world from 1.1. 2017 to 17.1. 2018: a cross-sectional study. BMC Infect Dis. 2019;19(1):1–5. doi:10.1186/s12879-019-3987-230606108
  • WHO. Summary table of SARS by country 1 november 2002–7 august 2003; 2003 Available from: http://www.who.int/entity/csr/sars/country/country2003_08_15.pdf. Accessed 11, 2020.
  • Leung GM, Hedley AJ, Ho LM, et al. The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann Intern Med. 2004;141(9):662. doi:10.7326/0003-4819-141-9-200411020-0000615520422
  • World Health Organization. Gender and COVID-19: Advocacy Brief, 14 May 2020. World Health Organization; 2020.
  • Butterworth M, McClellan B, Allansmith M. Influence of sex in immunoglobulin levels. Nature. 1967;214(5094):1224–1225. doi:10.1038/2141224a04169229
  • Kanda N, Tamaki K. Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol. 1999;103(2 Pt 1):282–288.9949320
  • Kanda N, Tsuchida T, Tamaki K. Testosterone inhibits immunoglobulin production by human peripheral blood mononuclear cells. Clin Exp Immunol. 1996;106(2):410–415. doi:10.1046/j.1365-2249.1996.d01-842.x8918592
  • Pinheiro I, Dejager L, Libert C. X-chromosome-located microRNAs in immunity: might they explain male/female differences? The X chromosome-genomic context may affect X-located miRNAs and downstream signaling, thereby contributing to the enhanced immune response of females. Bioessays. 2011;33(11):791–802. doi:10.1002/bies.20110004721953569
  • Brake SJ, Barnsley K, Lu W, McAlinden KD, Eapen MS, Sohal SS. Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-Cov-2 (Covid-19). 2020.
  • Dobbs LG. Pulmonary surfactant. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Annu Rev Med. 1989;40(1):431–446. doi:10.1146/annurev.me.40.020189.0022432658759
  • Park JE, Jung S, Kim A, Park J-E. MERS transmission and risk factors: a systematic review. BMC Public Health. 2018;18(1):574. doi:10.1186/s12889-018-5484-829716568
  • Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med. 2004;164(20):2206–2216. doi:10.1001/archinte.164.20.220615534156
  • Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-332171076
  • Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy. 2020;75(7):1730–1741. doi:10.1111/all.1423832077115
  • Li H, Wang S, Zhong F, et al. Age-dependent risks of incidence and mortality of COVID-19 in Hubei Province and other parts of China. Front Med. 2020;7:190.
  • Assessment RR. Outbreak of Novel Coronavirus Disease 2019 (COVID-19): Increased Transmission Globally–Fifth Update What is New in This Update? 2019.
  • The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (covid-19) — China, 2020. Chin CDC Weekly. 2020;2(8):113–122. doi:10.46234/ccdcw2020.032
  • Nishiura H. Case fatality ratio of pandemic influenza. Lancet Infect Dis. 2020;382(7):2061–2063. doi:10.1016/S1473-3099(10)70120-1
  • COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU).
  • Hyams KC, Murphy FM, Wessely S, et al. Responding to chemical, biological, or nuclear terrorism: the indirect and long-term health effects may present the greatest challenge. J Health Polit Policy Law. 2002;27(2):273–291. doi:10.1215/03616878-27-2-27312043900
  • Ogunleye OO, Basu D, Mueller D, Sneddon J, Seaton RA. Response to the novel corona virus (COVID-19) pandemic across Africa: successes, challenges and implications for the future. Front Pharmacol. 2020.
  • WHO. Electronic state parties self-assessment annual reporting. Available from: https://extranet.who.int/e-spar. Accessed 11, 2020.
  • Elovainio R, Pick A. COVID-19 and beyond: how can Africa’s health systems cope? OECD development matters, 7 april 2020. Available from: https://oecd-development-matters.org/2020/04/07/covid-19-andbeyond-how-can-africas-health-systems-cope/. Accessed 11, 2020.
  • Shigute Z, Mebratie AD, Alemu G, Bedi A. Containing the spread of COVID-19 in Ethiopia. J Glob Health. 2020;10(1). doi:10.7189/jogh.10.010369